1. Home
  2. DHX vs GNLX Comparison

DHX vs GNLX Comparison

Compare DHX & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DHI Group Inc.

DHX

DHI Group Inc.

HOLD

Current Price

$3.94

Market Cap

150.3M

ML Signal

HOLD

Logo Genelux Corporation

GNLX

Genelux Corporation

HOLD

Current Price

$2.93

Market Cap

133.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DHX
GNLX
Founded
1991
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
150.3M
133.0M
IPO Year
2007
2022

Fundamental Metrics

Financial Performance
Metric
DHX
GNLX
Price
$3.94
$2.93
Analyst Decision
Buy
Strong Buy
Analyst Count
2
4
Target Price
$6.25
$17.25
AVG Volume (30 Days)
129.1K
159.8K
Earning Date
05-05-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
9.47
EPS
0.04
N/A
Revenue
$127,826,000.00
$8,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$3.52
N/A
P/E Ratio
$96.25
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.44
$2.29
52 Week High
$4.33
$8.54

Technical Indicators

Market Signals
Indicator
DHX
GNLX
Relative Strength Index (RSI) 52.92 50.51
Support Level $3.76 $2.74
Resistance Level $4.00 $2.94
Average True Range (ATR) 0.25 0.12
MACD -0.03 -0.00
Stochastic Oscillator 33.94 60.15

Price Performance

Historical Comparison
DHX
GNLX

About DHX DHI Group Inc.

DHI Group Inc is a provider of software products, online tools, and services that deliver career marketplaces to candidates and employers in the United States. The company operates through two reportable segments: ClearanceJobs and Dice. Its brands enable recruiters and hiring managers to search, match, and connect with skilled technologists, particularly in technology and active government security clearance, while professionals find job opportunities, job advice, and personalized data. ClearanceJobs connects security-cleared professionals with employers in a secure environment and supports engagement through messaging and live video. Dice, which generates maximum revenue, is a destination for technology and engineering talent, offering job postings across a range of technology roles.

About GNLX Genelux Corporation

Genelux Corp is a late-stage biopharmaceutical firm focused on developing oncolytic viral immunotherapies for cancer. Its pipeline includes clinical and preclinical candidates designed to target tumor cells and stimulate an immune response against tumor-specific antigens. The company is focused on the development of next-generation oncolytic viral immunotherapies that are designed to generate a personalized multi-prong attack to overwhelm a tumor's sophisticated defense mechanisms.

Share on Social Networks: